Follow-up of Study AN004T to Assess the Persistence of AllerT Efficacy During the 2nd to 4th Season After Treatment

Mise à jour : Il y a 4 ans
Référence : NCT02143583

Femme et Homme

Extrait

Study aiming to evaluate the efficacy of a 2-month pre-seasonal treatment with an AllerT 50 µg or 100 µg maintenance dose administered in previous study AN004T in reducing symptoms of allergic rhinoconjunctivitis during the 2nd following birch pollen season.


Critère d'inclusion

  • Birch Pollen Allergy


Liens